RACHAEL MILLHAM-JONES: Open Payments
NPI 1093483364 · CLEBURNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 60 payments from 19 companies in 2025. Trend: 2023 $925 · 2024 $1,386 · 2025 $1,182
Food & beverage: $1,182
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $160 |
| Lundbeck LLC | 7 | $142 |
| Axsome Therapeutics, Inc. | 6 | $129 |
| Eisai Inc. | 1 | $125 |
| Novo Nordisk Inc | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| PFIZER INC. | 4 | $73 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $38 |
Products named: REXULTI, Auvelity, Leqembi, VRAYLAR, Ozempic, TRELEGY ELLIPTA, NURTEC ODT, UBRELVY.
Industry payments across TX — which companies pay providers there.
